|
gptkbp:instanceOf
|
company
|
|
gptkbp:acquisition
|
gptkb:XYZ_Biotech
|
|
gptkbp:annualVisitors
|
50 million USD
|
|
gptkbp:awards
|
Best_Biotech_Company_2020
|
|
gptkbp:CEO
|
gptkb:John_Smith
|
|
gptkbp:certifications
|
gptkb:ISO_13485
|
|
gptkbp:clinicalTrials
|
ongoing
|
|
gptkbp:collaborations
|
gptkb:University_of_Science
|
|
gptkbp:customerBase
|
hospitals
|
|
gptkbp:employees
|
200
|
|
gptkbp:foundedIn
|
1995
|
|
gptkbp:founder
|
gptkb:Jane_Doe
|
|
gptkbp:headCoach
|
gptkb:Dr._Emily_White
|
|
gptkbp:headquarters
|
gptkb:United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mikro-Gen
|
|
gptkbp:industry
|
biotechnology
|
|
gptkbp:investmentFocus
|
Venture_Capital_Firm_A
|
|
gptkbp:market
|
global
new_diagnostic_kit_2023
|
|
gptkbp:marketShare
|
15%
|
|
gptkbp:partnerships
|
gptkb:ABC_Pharmaceuticals
|
|
gptkbp:patentCitation
|
10
|
|
gptkbp:products
|
diagnostic_kits
|
|
gptkbp:researchAndDevelopment
|
20% of revenue
|
|
gptkbp:researchFocus
|
infectious diseases
|
|
gptkbp:sells
|
BioTech Expo 2023
|
|
gptkbp:services
|
laboratory services
|
|
gptkbp:socialResponsibility
|
community health initiatives
|
|
gptkbp:subsidiary
|
Mikro-Gen_USA
|
|
gptkbp:website
|
www.mikrogen.com
|